MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617062537 A) filed by Tacit Therapeutics, Inc. on May 18, 2026, for Trans-Splicing Nucleic Acid Molecules And Methods Of Use.
Inventor includes Nelles, David Allen.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present disclosure provides compositions, systems, and methods for promoting trans-splicing. In some examples, provided herein is a composition comprising or encoding a trans-splicing nucleic acid molecule comprising a 3' domain disclosed herein. In some embodiments, the 3' domain comprises one or more of the following domains: a nuclear retention domain, a stabilization domain, and a...